July 24, 2024
Podcast: If Cannabis Is Reclassified, What Will Happen to the Marketplace? – Diagnosing Health Care | Epstein Becker Green

Subscribe on Amazon Music / Audible, Apple Podcasts, Audacy, Deezer, Goodpods, iHeartRadio, Overcast, Pandora, PlayerFM, Spotify, YouTube, YouTube Music.

Will the reclassification of marijuana from a Schedule I to a Schedule III drug disrupt the cannabis marketplace? What consequences must industry stakeholders consider if the Drug Enforcement Administration’s proposal becomes a reality?

On this episode, special guests Anthony Minniti, a New Jersey-licensed pharmacist, and Stacey Udell, an accountant with expertise in representing cannabis operators across the United States, join Epstein Becker Green attorney Lisa Gora to discuss the regulatory domino effect and tax implications related to this major potential change to the cannabis industry.

About the Diagnosing Health Care Podcast

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.

Trouble listening to this podcast? Please contact us at [email protected] and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.

Subscribe to the Podcast

Podcast: If Cannabis Is Reclassified, What Will Happen to the Marketplace? – Diagnosing Health Care | Epstein Becker Green

Never miss an episode! Subscribe to Diagnosing Health Care on your preferred platform – Amazon Music / Audible, Apple Podcasts, Audacy, Deezer, Goodpods, iHeartRadio, Overcast, Pandora, PlayerFM, Spotify, YouTube, YouTube Music.

Spread the Word

Megaphone

Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition on LinkedIn, Facebook, X, YouTube, and YouTube Music, and your connections can subscribe for email notifications.

Leave a Reply